Drug/device policy review on cards in India for 2015
This article was originally published in SRA
Executive Summary
India's Central Drugs Standard Control Organization has outlined a list of policy initiatives that it plans to undertake in 2015. The proposal includes plans to update good manufacturing practice (GMP) requirements for both drugs and medical devices and strengthen regulations concerning the quality control of drugs, medical devices and cosmetics1.